ARQT - long - momentum and catalyst playArcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
This is not a financial advice!
Recent block buys
Upcoming catalyst in July 2024
Medium float of 78.91M
Short float 26.40%
ER is on the 14th of February - keep that in mind
We might see a correction to 4-5 level, where is a perfect buy zone
With enough volume and good ER we could break the last high zone 7.0 - 7.3
SL depends on your entry. If u enter now in the 6.5s SL under 5.3
If u enter in the 4-5 zone SL under 3.0
Most info on the chart.
Trade carefully!